藥物成份

共有 21645 個藥物成份

SULFAPERINE

• 關聯藥證數量: 1

SULFAPYRIDINE

• 關聯藥證數量: 1

SULFATHIOPHEN

• 關聯藥證數量: 1

SULFATHIOUREA

• 關聯藥證數量: 1

SULFIRAME(MONOSULFIRAM)

• 關聯藥證數量: 1

SULFOMUCOPOLYSACCHARIDES OF PANCREATIC ORIGIN

• 關聯藥證數量: 1

SULFONATE ION

• 關聯藥證數量: 1

SULFONMETHANE

• 關聯藥證數量: 1

SULFUR BIO-

• 關聯藥證數量: 1

SULFUR PRECIPITATED

• 關聯藥證數量: 1

SULFURIC ACID 480 MMOL/LAMMONIUM PARA-MOLYBDATE TETRAHYDRATE 26.7 MMOL/L

• 關聯藥證數量: 1

SULPROSTONE

• 關聯藥證數量: 1

SULTAMICILLIN TOSILATE DIHYDRATE

• 關聯藥證數量: 1

SULTHIAME

• 關聯藥證數量: 1

SUMBUL EXTRACT

• 關聯藥證數量: 1

SUNFLOWER SEED OIL

• 關聯藥證數量: 1

SUPER HARTOLAN

• 關聯藥證數量: 1

SURFACTANT WATER

• 關聯藥證數量: 1

SWEETMINT POWDER

• 關聯藥證數量: 1

SYALAMIN

• 關聯藥證數量: 1

SYNCHRON ALCOHOL (ETOH) REAGENT ：TRIS REACTION BUFFER(0.2M) ：41ML ALCOHOL DEHYDROGENASE(YEAST)(35KU/L) SYNCHRON ETOH CALIBRATOR ：ETHANOL：0-100MG/DL NAD (9MMOLE/L) IN TRIS BUFFER

• 關聯藥證數量: 1

SYNCHRON LX CCWA (KOH, DETERGENTS)....107ML

• 關聯藥證數量: 1

SYNCHRON 品管液是以新鮮冷凍之人類血漿配製，並採用乙烯乙二醇使其穩定。

• 關聯藥證數量: 1

SYNSTRONE

• 關聯藥證數量: 1

SYNTHETIC ARGININE VASOPRESSIN

• 關聯藥證數量: 1

SYNTHETIC OXYTOCIN

• 關聯藥證數量: 1

SYRUP

• 關聯藥證數量: 1

SYRUP SIMPLE

• 關聯藥證數量: 1

Safinamide mesilate

• 關聯藥證數量: 1

Salbutamol Sulphate contains 98.0% ~ 101.0% of C26H44N2O10S, calculated on the dried substance.

• 關聯藥證數量: 1

Salbutamol Sulphate contains not less than 98.0% and not more than 101.0% (dried substance).

• 關聯藥證數量: 1

Salicylamide contains not less than 98.0% and not more than 102.0% of C7H7NO2, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Salicylate Assay Reagent. Contains 25 mL of ferric nitrate in an aqueous nitric acid solution.\nSalicylate Calibrator Kit: Contains 1 x 5 mL of Negative Calibrator (Tris buffer) and 1 x 2 mL of 800 ug/mL salicylate in Tris buffer.

• 關聯藥證數量: 1

Salicylate Calibrator A (0μg/ml): buffer with stabilizers and preservativeSalicylate Calibrator B (300μg/ml): Salicylate in buffer with stabilizers and preservative.

• 關聯藥證數量: 1

Salmonella Antisera 0.09% sodium azide

• 關聯藥證數量: 1

Salmonella antisera are preparations of rabbit antiserum with 30%-50% glycerin.

• 關聯藥證數量: 1

Salts, preservatives, Deionized water

• 關聯藥證數量: 1

Sample Buffer POD: 0.3 mol/L Tris/HCl buffer solution, pH 8.0 - 8.2, with Tween 20 approximately 0.1 %, polygeline approximately 1 %, bovine serum approximately 5 %.\nPreservatives: approxirnately 5 mg/L amphotericin B and approximately 100 mg/L gentamicin.\n\nRF-Absorbent (lyophilized): Sheep antibodies targeted against human IgG-Fc fragment in phosphate buffered (10 mmol/L.) , p.H 7.2, saline solution (8.2 g/L).\nPreservative: Sodium azide (maximum 0.4 g/L).\n

• 關聯藥證數量: 1

Sample Diluent (50ml). Glycine buffered saline (pH 8.4 ± 0.1) containing bovine serum albumin and a preservative.

• 關聯藥證數量: 1

Sample Diluent-4.1 mL:\n0.85% NaCl\nReagent 1-4.1 mL:\nSpecimen Extraction Reagent, pH 7.0 buffer solution containing surfactant and reducing agent.\nReagent 2-1.2 mL:\nConjugate, pH 7.2 buffer solution containing surfactant, stabilizing proteins, and anti influenza A and B antibodies (mouse) each conjugated to Horseradish Peroxidase (HRP).\nWash-115 mL:\npH 7.2 phosphate buffer containing surfactant\nSubstrate-2.0 mL:\npH5.5 aqueous solution of tetramethylbenzidine (TMB) and hydrogen peroxide.\n\n

• 關聯藥證數量: 1

Sample Diluent/Negative Control─Phosphate buffered saline with 0.02% thimerosal as preservative.

• 關聯藥證數量: 1

Sample Diluent:\n0.85% NaCl\nReagent 1:\nSpecimen Extraction Reagent: pH 7.0 buffer solution containing surfactant and reducing agent.\nReagent 2:\nConjugate: pH 7.3 buffer solution containing surfactant, stabikizing proteins, 0.5% ProClin 300 solution, and two anti-Respiratory syncytial virus monoclonal antibodies (mouse) conjugated to Horseradish Peroxidase (HRP).\nOne of the two anti-RSV antibodies targets the nucleoprotein and the other targets the fusion protein. Contains 2.96% Gelatin Hydrolysate which is considered an irritant.\nWash:\npH 7.5 phosphate buffer containing surfactant.\nSubstrate:\npH 5.5 aqueous solution of tetramethylbenzidine (TMB) and hydrogen peroxide.\nPositive Control:\npH 7.5 buffered protein solution (fetal calf serum) containing inactivated respiratory syncytial virus.\nNegative Control:\npH 7.5 buffered protein solution (fetal calf serum).\nTest Devices:\nSurface coated with polyclonal anti-respiratory syncytial virus abtibody (goat) spotted with formalin inactivated respiratory

• 關聯藥證數量: 1

Sample Diluent\n0.85% NaCl in 0.1% ProClin 300 preservative.\nReagent 1\nSpecimen Extraction Reagent： pH 7.0 buffer solution containing surfactant and reducing agent. Preserved with 0.1% ProClin 300 preservative.\nReagent 2\nConjufate：pH 7.2 buffer solution containing surfactant, stabilizing proteins, 0.5% ProClin 300 preservative, and anti-influenza A and B antibodies (mouse) each conjugated to Horseradish Peroxidase (HRP).\nWash\nWash Solution：pH 7.2 phosphate buffer containing surfactant, 0.1% ProClin 300 preservative.\nSubstrate\nSubstrate：pH 5.5 aqueous solution of tetramethylbenzidine (TMB) and hydrogen peroxide.\nA Positive Control (B negative control)\nFormaldehyde-inactivated influenza A virus (A/Hong Kong/68 (H3N2)) suspension in a buffered protein solution, 0.03% Microcide II preservative.\nB Positive Control (A negative control)Formaldehyde-inactivated influenza B virus (B/Panama45/90) suspension in a buffered protein solution, 0.03% Microcide II preservative.\nExtraction Tubes\nTest Devices\nOne

• 關聯藥證數量: 1

Sample buffer\nTris-EDTA buffer\nLysis tube\nGlass beads\nMaster mix (8 reactions each)\n<0.0005% DNA polymerase complex\n<0.001% Internal Control - non-infectious DNA containing MRSA-primer binding sequences and a unique sequence for probe hybridization\n<0.002% primers\n<0.002% molecular probes\n<0.05% dATP, dCTP, dGTP, dTTP\nBovine serum albumin\nCabohydrate\nMgCl2\n<0.001% non-infectious Staphylococcus epidermidis genomic DNA (ATCC 14990)

• 關聯藥證數量: 1

Sample collection tubes with asasy diluent、\nSample collection swab

• 關聯藥證數量: 1

Sample diluent (ready for use) :\nPreservative: 0.01% thimerosal.

• 關聯藥證數量: 1

Sample diluent, ELP solution, Mammalian immunoglobulins anti-human gamma heavy chains, Mammalian immunoglobulins anti-human alpha heavy chains, Mammalian immunoglobulins anti-human mu heavy chains, Mammalian immunoglobulins anti-human kappa (free and bound) light chains, Mammalian immunoglobulins anti-human lambda (free and bound) light chains

• 關聯藥證數量: 1

Sapropterin dihydrochloride contains not less than 98.0 percent and not more than 102.0 percent of labeled amount of C9H17Cl2N5O3

• 關聯藥證數量: 1

Saxagliptin Hydrochloride contains NLT 98.0% and NMT 102.0% of C18H25N3O2·HCL, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Saxagliptin Hydrochloride contains not less than 98.0% and not more than 102.0% of C18H25N3O2HCl, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Saxagliptin monohydrate contains NLT 98.0% and NMT 102.0% of Saxagliptin monohydrate [C18H25N3O2‧H2O], calculated on anhydrous basis.

• 關聯藥證數量: 1

Scopolamine Butyl bromide contains not less than 98.0% and not more than 101.0% of C21H30BrNO4, calculated on the dried basis.

• 關聯藥證數量: 1

Scopolamine Butylbromide Content：98.0%~101.0%(dried substance)

• 關聯藥證數量: 1

Scopolamine Butylbromide (Hyoscine butylbromide) content:98.0 percent to 101.0 percent (dried substance)

• 關聯藥證數量: 1

Scopolamine Hydrobromide (Hyoscine Hydrobromide) Content：99.0%~101.0% (anhydrous substance)

• 關聯藥證數量: 1

Scopolamine N-Butylbromide contains not less than 98.0% and not more than 101.0% of C21H30BrNO4, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Secobarbital Enzyme, Polyclonal antibody reactive to secobarbital, NAD+,G6P

• 關聯藥證數量: 1

Secukinumab

• 關聯藥證數量: 1

Selegiline Hydrochloride contains 98.0%~101.0% of C13H18ClN, calculated on anhydrous substance.

• 關聯藥證數量: 1

Selinexor

• 關聯藥證數量: 1

Senkyu

• 關聯藥證數量: 1

Sennosides 60% NLT 90.0% and NMT 110.0% of the labeled amount of sennosides The labeled amount is NLT 60.0% (w/w), calculated on the dried basis..

• 關聯藥證數量: 1

Sennosides 80% (with maltodextrin)

• 關聯藥證數量: 1

Sennosides contains not less than 90.0% and not more than 110.0% of C42H36O20Ca, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sennosides contains not less than 90.0% and not more than 110.0% of the labeled amount of sennosides. The labeled amount is not less than 60.0%, calculated on the dried basis.

• 關聯藥證數量: 1

Sensi-DiscTM brand discs are 6-mm discs prepared by impregnating high quality absorbent paper with accurately determined amounts of antibiotic or other chemotherapeutic agents. Discs are clearly marked on both sides with letters and numbers desig-nating the agent and the drug content.(See chart giving concentrations of reactive ingredients.)

• 關聯藥證數量: 1

Sensi-DiscTM brand discs prepared by impregnating high quality absorbent paper with accurately determined amounts of antibiotic or other chemotherapeutic agents.Discs are clearly marked on both sides with letters and numbers designating the agent and the drug content. (See chart giving concentrations of reactive ingredients.)

• 關聯藥證數量: 1

Sequestering agent

• 關聯藥證數量: 1

Serratiopeptidase contains 2,000~2,600 Serratiopeptidase unit per mg.

• 關聯藥證數量: 1

Serratiopeptidase contains not less than 1600 Serratiopeptidase Units and not more than 2600 Serratiopeptidase Units per mg.

• 關聯藥證數量: 1

Serum separating gel: α-olefin-maleate ester oligomers.\nCoagulation accelerating membrane: Min-U-Sil and PVP, etc.\n

• 關聯藥證數量: 1

Setraline Hydrochloride contains not less than 97.5% and not more than 102.0% of C17H18Cl3N, calculated on anhydrous substance.

• 關聯藥證數量: 1

Sevelamer Carbonate contains Phosphate Binding Capacity 5.0-6.5 mmol/g of polymer (as dried basis)

• 關聯藥證數量: 1

Sevelamer Hydrochloride contains Phosphate Binding Capacity 5.2-6.5 mmol/g of polymer (on dried basis)

• 關聯藥證數量: 1

Seven specimens-LN 24-01 through LN 24-07

• 關聯藥證數量: 1

Sheep anti-T4 coated microtiter wells, 96 wells.\nT4 Reference Standards: 0, 2, 5, 10, 15, and 25 ug/dl, 1set, 1.0 ml.\nEnzyme Conjugate Concentrate (11x), 1.3 ml.\nEnzyme Conjugate Diluent, 13 ml.\nTMB Reagent, 11 ml.\nStop Solution (1N HCl), 11 ml.

• 關聯藥證數量: 1

Silde Ingredients: Cupric sulphate pentahydrate CuSO4 (5H2O) 1.7 mg (6.8 umol)

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S‧C6H8O7, calculated on anhydrous basis.

• 關聯藥證數量: 1

Sildenafil Citrate Content：98.0 per cent to 102.0 per cent (anhydrous substance).

• 關聯藥證數量: 1

Sildenafil Citrate contains 98.0%~102.0% of C22H30N6O4S．C6H8O7, calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains 98.0%~102.0% of C28H38N6O11S (anhydrous substance).

• 關聯藥證數量: 1

Sildenafil Citrate contains NLT 98.0% and NMT 102.0% of sildenafil citrate (C22H30N6O4S．C6H8O7), calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0 percent and not more than 102.0 percent of C28H38N6O11S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S.C6H8O7, calculated on the dried basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S.C6H8O7,calculated on the dried basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S‧C6H8O7, calculated on anhydrous basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S‧C6H8O7, calculated on the dried basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S？C6H8O7, calculated with reference to the dried basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H33N6O4S.C6H8O7 calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C28H38N6O11S calculated on the dried substance.

• 關聯藥證數量: 1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C28H38N6O11S, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Silica:suspended in biocide solution\nWasher Buffer 1:contains guanidine thiocyanate.\nWasher Buffer 2:contains organic buffer and biocide solution.\nWasher Buffer 3:contains inorganic buffer.\nElution Buffer:contains inorganic buffer.

• 關聯藥證數量: 1

Silodosin contains NLT 98.0% and NMT 102.0% of Silodosin (C25H32F3N3O4), calculated on the dried basis.

• 關聯藥證數量: 1

Silodosin contains not less than 98.0% and not more than 102.0% of C25H32F3N3O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Silodosin contains not less than 98.0%~102.0% of C25H32F3N3O4 (dried substance).

• 關聯藥證數量: 1

Silver Sulfadiazine contains not less than 98.0 percent and not more than 102.0 percent of C10H9AgN4O2S, calculated on the dried basis.

• 關聯藥證數量: 1

Silver Sulfadiazine contains not less than 98.0% and not more than 102% of C10H9AgN4O2S,calculated on the dried basis.

• 關聯藥證數量: 1

Silver Sulfazine contains not less than 98.0% and not more than 102.0% of C10H9AgN4O2S, calculated on anhydrous substance.

• 關聯藥證數量: 1

Silver sulphadiazine contains not less than 98% and not more than 102% of C10H9AgN4O2S,calculated on the dried basis.

• 關聯藥證數量: 1

Silymarin contains not less than 68 percent,calculated on the dried basis.

• 關聯藥證數量: 1